/content/dam/www/people-profile-photos/e/michael-emerman/michael-emerman-d.jpg
Emerman
Michael Emerman, PhD

Michael Emerman, PhD

  • Professor Emeritus, Human Biology Division, Fred Hutch
  • Professor Emeritus, Basic Sciences Division, Fred Hutch
  • Member, Pathogen-Associated Malignancies Integrated Research Center (PAM IRC), Fred Hutch

Background

Dr. Michael Emerman studies how our cells interact with HIV and related retroviruses. Over millennia, our cells and the cells of other primates that are susceptible to retrovirus infection have evolved strategies to rebuff the viruses. In turn, retroviruses like HIV have evolved their own strategies to overcome our defenses. Dr. Emerman charts the course of this evolution, examining how HIV adapted to humans from its origins as a primate retrovirus. Understanding ancient viral infections can give clues to our ability to resist — or succumb — to HIV. Insights into effective cellular antiviral defenses could also shed light on avenues for development of potential future antiretroviral therapies.

Education

Postdoc, Pasteur Institute (France)

PhD, University of Wisconsin-Madison

BS, Ohio State University

Find a Clinical Trial

Stories

All news
Virologist and HIV expert Dr. Michael Emerman retires Emerman considers mentorship his most important duty in science July 10, 2025
Cell biologist and former Fred Hutch division leader Dr. Jonathan Cooper retires Cooper sustained the distinct culture of Basic Sciences for four decades March 26, 2025
Evolutionary cell biologist Dr. Grant King named a Hanna Gray Fellow Long fascinated by life seen and unseen, King awarded eight years of funding to finish postdoctoral training at Fred Hutch and establish an independent lab January 29, 2025